Cancer Risks for PMS2-Associated Lynch Syndrome.

Ten Broeke, Sanne W; van der Klift, Heleen M; Tops, Carli M J; Aretz, Stefan; Bernstein, Inge; Buchanan, Daniel D; de la Chapelle, Albert; Capella, Gabriel; Clendenning, Mark; Engel, Christoph; Gallinger, Steven; Gomez Garcia, Encarna; Figueiredo, Jane C; Haile, Robert; Hampel, Heather L; Hopper, John L; Hoogerbrugge, Nicoline; von Knebel Doeberitz, Magnus; Le Marchand, Loic; Letteboer, Tom G W; Jenkins, Mark A; Lindblom, Annika; Lindor, Noralane M; Mensenkamp, Arjen R; Møller, Pål; Newcomb, Polly A; van Os, Theo A M; Pearlman, Rachel; Pineda, Marta; Rahner, Nils; Redeker, Egbert J W; Olderode-Berends, Maran J W; Rosty, Christophe; Schackert, Hans K; Scott, Rodney; Senter, Leigha; Spruijt, Liesbeth; Steinke-Lange, Verena; Suerink, Manon; Thibodeau, Stephen; Vos, Yvonne J; Wagner, Anja; Winship, Ingrid; Hes, Frederik J; Vasen, Hans F A; Wijnen, Juul T; Nielsen, Maartje; Win, Aung Ko.
J Clin Oncol; 36(29): 2961-2968, 2018 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-30161022

Não foram localizados documentos relacionados